OnKure Therapeutics, Inc. Class A Share Price
NASDAQ: OKUR | Micro CapOnKure Therapeutics, Inc. Class A Stock Performance
OnKure Therapeutics, Inc. Class A Share Price Today
As of 30 October 2026, OnKure Therapeutics, Inc. Class A's share price is $2.60. The stock opened at $2.66, compared to its previous close of $2.62. During today's trading session, OnKure Therapeutics, Inc. Class A's share price traded between $2.49 and $2.67, with an average price of $2.58. Over the past 52 weeks, the stock has recorded a high of $5.30 and a low of $2.03. In terms of performance, OnKure Therapeutics, Inc. Class A's share price has declined by 50.71% over the last six months and is down 21.69% on a year-on-year basis.
OnKure Therapeutics, Inc. Class A Share Price Chart
OnKure Therapeutics, Inc. Class A Quarterly Profit & Loss
All figures in USD
OnKure Therapeutics, Inc. Class A Annual Profit & Loss
All figures in USD
About OnKure Therapeutics, Inc. Class A
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
OnKure Therapeutics, Inc. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.72 | $2.60 | -6.31% |
Sep 2026 | $3.64 | $2.77 | -27.73% |
Aug 2026 | $3.78 | $3.84 | -0.13% |
Jul 2026 | $4.64 | $3.85 | -15.31% |
Jun 2026 | $4.46 | $4.54 | +7.84% |
May 2026 | $5.25 | $4.21 | -20.19% |
Apr 2026 | $4.12 | $5.28 | +28.03% |
Mar 2026 | $2.65 | $4.12 | +52.59% |
Feb 2026 | $2.66 | $2.70 | +1.31% |
Jan 2026 | $2.93 | $2.67 | -6.82% |
Dec 2025 | $2.94 | $2.86 | -4.51% |
Nov 2025 | $3.44 | $3.00 | -9.79% |